🔗 Visit the ClinicalTrials.gov page for NCT00880282
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures. | PLoS One | 2011 | 1.34 |
| 2 | Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma. | Eur J Cancer | 2011 | 1.15 |
| 3 | A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. | Front Oncol | 2013 | 0.95 |
| 4 | Targeted Therapy of Ewing's Sarcoma. | Sarcoma | 2010 | 0.86 |
| 5 | Molecular profiling of childhood cancer: Biomarkers and novel therapies. | BBA Clin | 2014 | 0.86 |
| 6 | Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities. | Pediatr Res | 2012 | 0.82 |
| 7 | Targeting angiogenesis in childhood sarcomas. | Sarcoma | 2010 | 0.77 |
| 8 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |